Chronic psychosocial stress exacerbates impairment of synaptic plasticity in β-amyloid rat model of alzheimer's disease: Prevention by nicotine

Current Alzheimer Research

Volumn 8, Issue 7, 2011, Pages 718-731

  Alkadhi, Karim A ^a   Alzoubi, Karem H ^b   Srivareerat, Marisa ^a   Tran, Trinh T ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Alzheimer's; Calcineurin; Late phase LTP; Nicotine; Rat model

Indexed keywords

AMYLOID BETA PROTEIN; CALCINEURIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; NICOTINE; PROTEIN KINASE C;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPAL CA1 REGION; IMMUNOBLOTTING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; MENTAL STRESS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; MALE; NEURONAL PLASTICITY; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL;

EID: 80053563202     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511797633188     Document Type: Article

References (118)

1. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 43: 293-300 (1993).
2. Hillier V, Salib E. A case-control study of smoking and Alzheimer's disease. Int J Geriatr Psychiatry 12: 295-300 (1997).
3. Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse PA. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology (Berl) 142: 334-342 (1999).
4. Ulrich J, Johannson-Locher G, Seiler WO, Stahelin HB. Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol 94: 450-454 (1997).
5. Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA. Chronic nicotine restores normal Abeta levels and prevents short-term memory and E-LTP impairment in Abeta rat model of Alzheimer's disease. Neurobiol Aging (in press, published online ahead of press) (2009).
6. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706: 181-193 (1996).
7. Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, et al. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology (Berl) 95: 171-175 (1988).
8. Fujii S, Ji Z, Morita N, Sumikawa K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846: 137-143 (1999).
9. Levin ED, Torry D. Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology (Berl) 123: 88-97 (1996).
10. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA. Nicotine blocks stress-induced impairment of spatial memory and long-term potentiation of the hippocampal CA1 region. Int J Neuropsychopharmacol 9: 417-426 (2006).
11. Levin ED, Wilson W, Rose JE, McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15: 429-436 (1996).
12. Levin ED, Christopher NC, Briggs SJ, Rose JE. Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Res Cogn Brain Res 1: 137-143 (1993).
13. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, et al. Nicotine effects on adults with attention-deficit/ hyperactivity disorder. Psychopharmacology (Berl) 123: 55-63 (1996).
14. Newhouse PA, Potter A, Levin ED. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11: 206-228 (1997).
15. Alzoubi KH, Aleisa AM, Gerges NZ, Alkadhi KA. Nicotine reverses adult-onset hypothyroidism-induced impairment of learning and memory: Behavioral and electrophysiological studies. J Neurosci Res 84: 944-953 (2006).
16. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 44: 5-21 (2004).
17. Abraham WC, Williams JM. Properties and mechanisms of LTP maintenance. Neuroscientist 9: 463-474 (2003).
18. Lisman J, Schulman H, Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3: 175-190 (2002).
19. Bozon B, Kelly A, Josselyn SA, Silva AJ, Davis S, Laroche S. MAPK, CREB and zif268 are all required for the consolidation of recognition memory. Philos Trans R Soc Lond B Biol Sci 358: 805-814 (2003).
20. Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P. Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824: 300-303 (1999).
21. Dudek SM, Bear MF. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci USA 89: 4363-4367 (1992).
22. Mulkey RM, Malenka RC. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9: 967-975 (1992).
23. Waxham MN, Aronowski J. Ca2+/calmodulin-dependent protein kinase II is phosphorylated by protein kinase C in vitro. Biochemistry 32: 2923-2930 (1993).
24. Stanton PK. LTD, LTP, and the sliding threshold for long-term synaptic plasticity. Hippocampus 6: 35-42 (1996).
25. Mulkey RM, Endo S, Shenolikar S, Malenka RC. Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal longterm depression. Nature 369: 486-488 (1994).
26. Foy MR, Stanton ME, Levine S, Thompson RF. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav Neural Biol 48: 138-149 (1987).
27. Diamond DM, Fleshner M, Rose GM. Psychological stress repeatedly blocks hippocampal primed burst potentiation in behaving rats. Behav Brain Res 62: 1-9 (1994).
28. Kim JJ, Foy MR, Thompson RF. Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation. Proc Natl Acad Sci USA 93: 4750-4753 (1996).
29. Gerges NZ, Alzoubi KH, Park CR, Diamond DM, Alkadhi KA. Adverse effect of the combination of hypothyroidism and chronic psychosocial stress on hippocampus-dependent memory in rats. Behav Brain Res 155: 77-84 (2004).
30. Ohl F, Michaelis T, Vollmann-Honsdorf GK, Kirschbaum C, Fuchs E. Effect of chronic psychosocial stress and long-term cortisol treatment on hippocampus-mediated memory and hippocampal volume: a pilot-study in tree shrews. Psychoneuroendocrinology 25: 357-363 (2000).
31. Fuchs E, Flugge G. Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci Biobehav Rev 23: 295-300 (1998).
32. Kim JJ, Yoon KS. Stress: metaplastic effects in the hippocampus. Trends Neurosci 21: 505-509 (1998).
33. Reul JM, Rothuizen J, de Kloet ER. Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors. J Steroid Biochem Mol Biol 40: 63-69 (1991).
34. Lorens SA, Hata N, Handa RJ, Van de Kar LD, Guschwan M, Goral J, et al. Neurochemical, endocrine and immunological responses to stress in young and old Fischer 344 male rats. Neurobiol Aging 11: 139-150 (1990).
35. Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathe AA, Johns CA, et al. Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry 143: 300-305 (1986).
36. Landfield PW, Eldridge JC. Evolving aspects of the glucocorticoid hypothesis of brain aging: hormonal modulation of neuronal calcium homeostasis. Neurobiol Aging 15: 579-588 (1994).
37. Kerr DS, Campbell LW, Thibault O, Landfield PW. Hippocampal glucocorticoid receptor activation enhances voltage-dependent Ca2+ conductances: relevance to brain aging. Proc Natl Acad Sci USA 89: 8527-8531 (1992).
38. Greenwald BS, Mathe AA, Mohs RC, Levy MI, Johns CA, Davis KL. Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry 143: 442-446 (1986).
39. Landfield PW, Waymire JC, Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 202: 1098-1102 (1978).
40. Pedersen WA, Wan R, Mattson MP. Impact of aging on stressresponsive neuroendocrine systems. Mech Ageing Dev 122: 963-983 (2001).
41. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886: 172-189 (2000).
42. Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48: 755-765 (2000).
43. Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biol Psychiatry 65: 918-926 (2009).
44. Alkadhi KA, Srivareerat M, Tran TT. Chronic nicotine prevents impairment of long-term memory caused by Aβ infusion and chronic stress in a rat model of Alzheimer's disease. Mol. Cell. Neurosci (in press) xx:xx-xx (2010).
45. Aleisa AM, Alzoubi KH, Alkadhi KA. Chronic but not acute nicotine treatment reverses stress-induced impairment of LTP in anesthetized rats. Brain Res 1097: 78-84 (2006).
46. Alzoubi KH, Aleisa AM, Alkadhi KA. Effect of chronic stress or nicotine on hypothyroidism-induced enhancement of LTD: electrophysiological and molecular studies. Neurobiol Dis 32: 81-87 (2008).
47. Gerges NZ, Stringer JL, Alkadhi KA. Combination of hypothyroidism and stress abolishes early LTP in the CA1 but not dentate gyrus of hippocampus of adult rats. Brain Res 922: 250-260 (2001).
48. Alkadhi KA, Alzoubi KH, Aleisa AM, Tanner FL, Nimer AS. Psychosocial stress-induced hypertension results from in vivo expression of long-term potentiation in rat sympathetic ganglia. Neurobiol Dis 20: 849-857 (2005).
49. Nitta A, Itoh A, Hasegawa T, Nabeshima T. beta-Amyloid proteininduced Alzheimer's disease animal model. Neurosci Lett 170: 63-66 (1994).
50. Tran TT, Srivareerat M, Alkadhi KA. Chronic psychosocial stress triggers cognitive impairment in a novel at-risk model of Alzheimer's disease. Neurobiol Dis 37:756-763 (2010).
51. Paxinos G, Watson C. The rat brain in sterotaxic coordinates. Second edition. Academic Press Inc. (1986).
52. Gerges NZ, Alkadhi KA. Hypothyroidism impairs late LTP in CA1 region but not in dentate gyrus of the intact rat hippocampus: MAPK involvement. Hippocampus 14: 40-45 (2004).
53. Alzoubi KH, Gerges NZ, Aleisa AM, Alkadhi KA. Levothyroxin restores hypothyroidism-induced impairment of hippocampusdependent learning and memory: Behavioral, electrophysiological, and molecular studies. Hippocampus 19: 66-78 (2009).
54. Thiels E, Xie X, Yeckel MF, Barrionuevo G, Berger TW. NMDA receptor-dependent LTD in different subfields of hippocampus in vivo and in vitro. Hippocampus 6: 43-51 (1996).
55. Aleisa AM, Alzoubi KH, Alkadhi KA. Nicotine prevents stressinduced enhancement of long-term depression in hippocampal area CA1: electrophysiological and molecular studies. J Neurosci Res 83: 309-317 (2006).
56. Alzoubi KH, Aleisa AM, Alkadhi KA. Adult-onset hypothyroidism facilitates and enhances LTD: reversal by chronic nicotine treatment. Neurobiol Dis 26: 264-272 (2007).
57. Alzoubi KH, Gerges NZ, Alkadhi KA. Levothyroxin restores hypothyroidism- induced impairment of LTP of hippocampal CA1: electrophysiological and molecular studies. Exp Neurol 195: 330-341 (2005).
58. Gerges NZ, Alzoubi KH, Alkadhi KA. Role of phosphorylated CaMKII and calcineurin in the differential effect of hypothyroidism on LTP of CA1 and dentate gyrus. Hippocampus 15:480-489 (2005).
59. Norman ED, Thiels E, Barrionuevo G, Klann E. Long-term depression in the hippocampus in vivo is associated with protein phosphatase- dependent alterations in extracellular signal-regulated kinase. J Neurochem 74: 192-198 (2000).
60. Aleisa AM, Alzoubi KH, Gerges NZ, Alkadhi KA. Chronic psychosocial stress-induced impairment of hippocampal LTP: possible role of BDNF. Neurobiol Dis 22: 453-462 (2006).
61. Alzoubi KH, Aleisa AM, Alkadhi KA. Molecular studies on the protective effect of nicotine in adult-onset hypothyroidism-induced impairment of long-term potentiation. Hippocampus 16: 861-874 (2006).
62. Doyere V, Errington ML, Laroche S, Bliss TV. Low-frequency trains of paired stimuli induce long-term depression in area CA1 but not in dentate gyrus of the intact rat. Hippocampus 6: 52-57 (1996).
63. Alzoubi KH, Aleisa AM, Alkadhi KA. Nicotine prevents disruption of the late phase LTP-related molecular cascade in adult-onset hypothyroidism. Hippocampus 17: 654-664 (2007).
64. Alzoubi KH, Alkadhi KA. A critical role of CREB in the impairment of late-phase LTP by adult onset hypothyroidism. Exp Neurol 203: 63-71 (2007).
65. Frey U, Schibler A, Kraemer R. The interrupter technique--a renaissance of a non-invasive approach for lung function testing in infants and children. Agents Actions Suppl 40: 64-72 (1993).
66. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79: 59-68 (1994).
67. Barco A, Alarcon JM, Kandel ER. Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell 108: 689-703 (2002).
68. Puzzo D, Arancio O. Fibrillar beta-amyloid impairs the late phase of long term potentiation. Curr Alzheimer Res 3: 179-183 (2006).
69. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114: 1624-1634 (2004).
70. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 99: 13217-13221 (2002).
71. Tong L, Thornton PL, Balazs R, Cotman CW. Beta -amyloid-(1- 42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival Is not compromised. J Biol Chem 276: 17301-17306 (2001).
72. Trentani A, Kuipers SD, Ter Horst GJ, Den Boer JA. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur J Neurosci 15: 1681-1691 (2002).
73. Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 85: 1312-1323 (2003).
74. Nakayama H, Numakawa T, Ikeuchi T, Hatanaka H. Nicotineinduced phosphorylation of extracellular signal-regulated protein kinase and CREB in PC12h cells. J Neurochem 79: 489-498 (2001).
75. Hu M, Liu QS, Chang KT, Berg DK. Nicotinic regulation of CREB activation in hippocampal neurons by glutamatergic and nonglutamatergic pathways. Mol Cell Neurosci 21: 616-625 (2002).
76. Berridge MJ. Calcium hypothesis of Alzheimer's disease. Pflugers Arch 459: 441-449 (2010).
77. Billingsley ML, Ellis C, Kincaid RL, Martin J, Schmidt ML, Lee VM, et al. Calcineurin immunoreactivity in Alzheimer's disease. Exp Neurol 126: 178-184 (1994).
78. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 284: 310-316 (2001).
79. Mbebi C, See V, Mercken L, Pradier L, Muller U, Loeffler JP. Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J Biol Chem 277: 20979-20990 (2002).
80. Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM, et al. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci 25: 4649-4658 (2005).
81. Cardoso SM, Oliveira CR. The role of calcineurin in amyloid-betapeptides- mediated cell death. Brain Res 1050: 1-7 (2005).
82. Zhao WQ, Santini F, Breese R, Ross D, Zhang XD, Stone DJ, et al. Inhibition of calcineurin-mediated endocytosis and AMPA receptor prevent amyloid {beta} oligomer-induced synaptic disruption. J Biol Chem 285: 7619-7632 (2010).
83. Agostinho P, Lopes JP, Velez Z, Oliveira CR. Overactivation of calcineurin induced by amyloid-beta and prion proteins. Neurochem Int 52: 1226-1233 (2008).
84. Dineley KT, Hogan D, Zhang WR, Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 88: 217-224 (2007).
85. Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell 7: 824-835 (2008).
86. Taglialatela G, Hogan D, Zhang WR, Dineley KT. Intermediateand long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res 200: 95-99 (2009).
87. Mulkey RM, Herron CE, Malenka RC. An essential role for protein phosphatases in hippocampal long-term depression. Science 261: 1051-1055 (1993).
88. D'Alcantara P, Schiffmann SN, Swillens S. Bidirectional synaptic plasticity as a consequence of interdependent Ca2+-controlled phosphorylation and dephosphorylation pathways. Eur J Neurosci 17: 2521-2528 (2003).
89. Beattie EC, Carroll RC, Yu X, Morishita W, Yasuda H, von Zastrow M, et al. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci 3: 1291-1300 (2000).
90. Lee HK, Kameyama K, Huganir RL, Bear MF. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 21: 1151-1162 (1998).
91. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL. Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405: 955-959 (2000).
92. Thiels E, Kanterewicz BI, Knapp LT, Barrionuevo G, Klann E. Protein phosphatase-mediated regulation of protein kinase C during long-term depression in the adult hippocampus in vivo. J Neurosci 20: 7199-7207 (2000).
93. Fujii S, Sumikawa K. Nicotine accelerates reversal of long-term potentiation and enhances long-term depression in the rat hippocampal CA1 region. Brain Res 894: 340-346 (2001).
94. Ho OH, Delgado JY, O'Dell TJ. Phosphorylation of proteins involved in activity-dependent forms of synaptic plasticity is altered in hippocampal slices maintained in vitro. J Neurochem 91: 1344-1357 (2004).
95. Errington ML, Bliss TV, Richter-Levin G, Yenk K, Doyere V, Laroche S. Stimulation at 1-5 Hz does not produce long-term depression or depotentiation in the hippocampus of the adult rat in vivo. J Neurophysiol 74: 1793-1799 (1995).
96. Chen H, Fu Y, Sharp BM. Chronic nicotine self-administration augments hypothalamic-pituitary-adrenal responses to mild acute stress. Neuropsychopharmacology 33: 721-730 (2008).
97. Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamo- pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 23: 103-113 (1998).
98. Yu G, Sharp BM. Nicotine self-administration diminishes stressinduced norepinephrine secretion but augments adrenergicresponsiveness in the hypothalamic paraventricular nucleus and enhances adrenocorticotropic hormone and corticosterone release. J Neurochem 112: 1327-1337 (2010).
99. Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL. Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res 1292: 191-198 (2009).
100. Mitsuyama F, Futatsugi Y, Okuya M, Karagiozov K, Peev N, Kato Y, et al. Amyloid beta: a putative intra-spinal microtubuledepolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease. Ital J Anat Embryol 114: 109-120 (2009).
101. Kawasumi M, Hashimoto Y, Chiba T, Kanekura K, Yamagishi Y, Ishizaka M, et al. Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein-relevant insults. Neurosignals 11: 236-250 (2002).
102. Chen TJ, Wang DC, Chen SS. Amyloid-beta interrupts the PI3KAkt- mTOR signaling pathway that could be involved in brainderived neurotrophic factor-induced Arc expression in rat cortical neurons. J Neurosci Res 87: 2297-2307 (2009).
103. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y. PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc Natl Acad Sci USA 107: 7060-7065 (2010).
104. Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, et al. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol Psychiatry 14: 206-222 (2009).
105. Lu Y, Zhou J, Xu C, Lin H, Xiao J, Wang Z, et al. JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem 21: 305-314 (2008).
106. Delibas N, Doguc DK, Sutcu R, Eroglu E, Gokalp O. EFFECT of nicotine on hippocampal nicotinic acetylcholine alpha7 receptor and NMDA receptor subunits 2A and 2B expression in young and old rats. Int J Neurosci 115: 1151-1163 (2005).
107. Yamazaki Y, Jia Y, Niu R, Sumikawa K. Nicotine exposure in vivo induces long-lasting enhancement of NMDA receptor-mediated currents in the hippocampus. Eur J Neurosci 23: 1819-1828 (2006).
108. Capsoni S, Cattaneo A. On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease. Cell Mol Neurobiol 26: 619-633 (2006).
109. Cirulli F, Alleva E. The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front Neuroendocrinol 30: 379-395 (2009).
110. French KL, Granholm AC, Moore AB, Nelson ME, Bimonte- Nelson HA. Chronic nicotine improves working and reference memory performance and reduces hippocampal NGF in aged female rats. Behav Brain Res 169: 256-262 (2006).
111. Garrido R, Malecki A, Hennig B, Toborek M. Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons. Brain Res 861: 59-68 (2000).
112. Garrido R, Mattson MP, Hennig B, Toborek M. Nicotine protects against arachidonic-acid-induced caspase activation, cytochrome c release and apoptosis of cultured spinal cord neurons. J Neurochem 76: 1395-1403 (2001).
113. Dajas-Bailador FA, Lima PA, Wonnacott S. The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism. Neuropharmacology 39: 2799-2807 (2000).
114. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383: 713-716 (1996).
115. Ji D, Lape R, Dani JA. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31: 131-141 (2001).
116. Mansvelder HD, McGehee DS. Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27: 349-357 (2000).
117. Alkondon M, Braga MF, Pereira EF, Maelicke A, Albuquerque EX. alpha7 nicotinic acetylcholine receptors and modulation of gabaergic synaptic transmission in the hippocampus. Eur J Pharmacol 393: 59-67 (2000).
118. Klann E, Thiels E. Modulation of protein kinases and protein phosphatases by reactive oxygen species: implications for hippocampal synaptic plasticity. Prog Neuropsychopharmacol Biol Psychiatry 23: 359-376 (1999).